Protein phosphorylation is a ubiquitous and key step in signaling pathways. For flow cytometry staining, the right protocol can help accurately capture these phosphorylated targets for clear-cut data.
Much of what biologists know about the human immune system has been — quite literally — illuminated by flow cytometry. For more than 70 years, this technology has evolved to become one of immunology’s ...
ANTIBODY TITRATION is critical to the success of any flow cytometry experiment. This is even more so in microflow cytometric analysis of extracellular vesicles (EVs), where removing excess antibodies ...
The UAB Flow Cytometry Lab is home to a staff of medical laboratory professionals who perform complex testing using state-of-the-art flow cytometry equipment. This testing, through research, education ...
The interaction between cells in the central nervous system and immune cells are key in neuroinflammation, and play a role in the survival of neurons during neuropathology. Flow cytometry is a ...
The StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 Dyes offer maximal brightness for improved resolution. HERCULES, Calif.–November 2, 2020–Bio-Rad Laboratories, Inc. (NYSE: BIO ...
Individual cells are concentrated in a flow cell (or tube) and then pass a laser, which detects a fluorescent signal. This is then analyzed by sophisticated software, producing data on the parameter ...
Around the same time, Mack Fulwyler, an engineer working at Los Alamos National Laboratory, needed to separate particles, so he drew on existing techniques to create droplets to separate cells from a ...
With flow cytometry, as with many technologies that enjoy continuous use, we can see an evolution of capabilities. Spectral analysis, image capture, and artificial intelligence are just a few of the ...
A research team from George R Brown School of Engineering and Computing (Rice University; TX, USA), led by Peter Lillehoj and Kevin Mchugh, have developed an innovative AI-enabled microfluidic ...
T cells genetically engineered to express a lab-designed chimeric-antigen receptor, or CAR, offer many patients with blood cancer a new treatment option. But while these T cells may have lifesaving ...